Yu, H.-J.; Chuang, M.-N.; Chu, C.-L.; Wu, P.-L.; Ho, S.-C.; Kuo, H.-C.
Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia. J. Clin. Med. 2021, 10, 1381.
https://doi.org/10.3390/jcm10071381
AMA Style
Yu H-J, Chuang M-N, Chu C-L, Wu P-L, Ho S-C, Kuo H-C.
Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia. Journal of Clinical Medicine. 2021; 10(7):1381.
https://doi.org/10.3390/jcm10071381
Chicago/Turabian Style
Yu, Hun-Ju, Meng-Ni Chuang, Chiao-Lun Chu, Pei-Lin Wu, Shu-Chen Ho, and Ho-Chang Kuo.
2021. "Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia" Journal of Clinical Medicine 10, no. 7: 1381.
https://doi.org/10.3390/jcm10071381
APA Style
Yu, H.-J., Chuang, M.-N., Chu, C.-L., Wu, P.-L., Ho, S.-C., & Kuo, H.-C.
(2021). Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia. Journal of Clinical Medicine, 10(7), 1381.
https://doi.org/10.3390/jcm10071381